Share this article

In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. Human epidermal growth factor receptor 2 (HER2) tests, using biopsied tissue, typically breast tissue, are carried out to detect over-expression of the HER2 protein, or additional copies HER2/neu gene encoding for the protein; the outcome of which may guide therapies to treat certain breast cancers, along with some ovarian cancers uterine cancers, stomach cancers, and lung cancers. GlobalData uses proprietary data and analytics to provide a comprehensive report on the her2 amplification tests devices market, including market shares of different players within the Netherlands. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Netherlands HER2 Amplification Tests Market Share

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

In 2022, GlobalData’s Market Model methodology determined that the leading player in the her2 amplification tests market in the Netherlands was F. Hoffmann-La Roche followed by Agilent Technologies, Abbott Laboratories, Danaher, Merck, Thermo Fisher Scientific, Sysmex and Biocare Medical.

HER Tests includes Immunohistochemistry (IHC) Tests, In Situ Hybridization (ISH) Tests, and Comparative genomic Hybridization (aCGH) Tests.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the her2 amplification tests devices market within the Netherlands was expected to be over $0.6m in 2022.

For the latest complete market share analysis of her2 amplification tests device market in the Netherlands, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.